Leustatin

This page contains recent news articles, when available, and an overview of Leustatin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Leustatin
(when available)

Pharmacology and use:
Cladribine is a synthetic antineoplastic agent indicated for the treatment of active Hairy Cell Leukemia as defined by clinically significant anemia, neutropenia, thrombocytopenia or disease-related symptoms. Cladribine is an antimetabolite. Cladribine's action is cell cycle-phase nonspecific; cladribine affects both dividing and resting lymphocytes. For the treatment of active Hairy Cell Leukemia as defined by clinically significant anemia, neutropenia, thrombocytopenia or disease-related symptoms

Mechanism Of Action:
Cladribine is structurally related to fludarabine and pentostatin but has a different mechanism of action. It is phosphorylated by deoxycytidine kinase to the corresponding nucleotide CdATP which accumulates and is incorporated into the DNA of cells such as lymphocytes. The phosphorylated metabolites of cladribine tend to accumulate in cells with a high ratio of deoxycytidine kinase activity to 5' nucleotidase activity (lymphocytes, monocytes ) and are converted to the active triphosphate deoxynucleotide. Intracellular accumulation of toxic deoxynucleotides selectively kills these cells, which become unable to properly repair single-strand DNA breaks, leading to disruption of cell metabolism. In addition, there is some evidence that deoxynucleotides are incorporated into the DNA of dividing cells and impair DNA synthesis. Cladribine also induces apoptosis (a form of programmed cell death in sensitive cells). Cladribine is resistant to the action of adenosine deaminase (ADA), which normally deaminates deoxyadenosine to deoxyinosine.

News Articles on Cladribine

Hairy cell leukemia  -  Feb 2, 2008
Cladribine (Leustatin). Most treatment regimens for hairy cell leukemia begin with cladribine. You receive a continuous infusion of the drug into a vein ... CNN

Q4 2004 Illinois Tool Works Inc. Earnings Conference Call - Part 3.  -  Jan 27, 2005
ELAINE LEUSTATIN: So it is not in the forecast, you will have to do it in the second half ... ELAINE LEUSTATIN: Let's go back to the leasing and operation, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

WPP и Interpublic Group получили креативный Ñ?ккаунт Johnson & …  -  Nov 7, 2008
будут работать Ñ? такими брендами, как болеутолÑ?ющими Duragesic и Ultram ER, а также лекарÑ?твами длÑ? лечениÑ? рака Procrit, Velcade и Leustatin и другими. ... Sostav.ru

WPP, IPG Take J&J's US Creative  -  Nov 5, 2008
J&J's pain drugs include Duragesic and Ultram, its reproductive health/urology drugs, Ortho and Terazol, and its cancer drugs, Velcade and Leustatin. Adweek

Builders, landowners grab top-dollar tables by Lerner  -  Feb 6, 2005
One of Scripps' most vaunted achievements has been the development of a drug called Leustatin, which has effectively cured hairy cell leukemia, ... Palm Beach Post

Back to last page  -  Jan 24, 2006
Studies are also being conducted with the immune system modulating drug cladribine (Leustatin). Another potential treatment for MS is monoclonal antibodies, ... Intelihealth.com

Financing cancer battle bruised by government-industry-academia …  -  May 7, 2007
Back in the '80s, Carson developed a new agent, now marketed as Leustatin, for the treatment of a form of leukemia. The drug, he said, has resulted in ... Free with registration - San Diego Business Journal - AccessMyLibrary.com

Copyright Harvard Health Publications 2007  -  Aug 27, 2007
...methotrexate (Folex, Methotrexate LPF, Rheumatrex), cyclophosphamide (Cytoxan, Neosar), mitoxantrone (Novantrone) and cladribine (Leustatin). HealthCentral.com

CBS Newsman Ed Bradley Dies of CLL Complications  -  Nov 9, 2006
Nucleoside analogs, such as Fludara (fludarabine) and Leustatin (cladribine), have activity against indolent lymphoid malignancies, including CLL. ... MedPage Today

J&J's Japanese subsidiary marks decline in sales, blaming NHI...  -  Apr 16, 2007
The NDA for the drug with an additional indication of ovarian cancer was filed in the same month, as was one for Leustatin (cladribine) in the treatment of ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

WILL SCRIPPS REALLY BE WORTH IT?  -  Mar 15, 2005
As an example, he trots out one of Scripps' best-known discoveries, the cancer drug Leustatin. It's manufactured in New Jersey, not San Diego. ... Pay-Per-View - Palm Beach Post - NewsBank

Janssen to upgrade medical representatives in oncology, CNS.  -  Sep 18, 2006
Leustatin Injection (cladribine) is for the treatment of hairy cell leukaemia and other malignant tumours. Itrizole (itraconazole) is an antifungal drug for ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones

CAN SCRIPPS-PLANCK PAY OFF?  -  Sep 18, 2007
While Scripps developed the leukemia drug, Leustatin, in San Diego, it is manufactured in New Jersey. "Academic research," Mr. Cortright said, ... Pay-Per-View - Palm Beach Post - NewsBank

SuperGen, Inc., Dublin, CA, Aug. 18 (DDMAC).(HUMAN DRUGS & …  -  Sep 1, 2005
In fact, it appears that another purine analog, Ortho Biotech Products' Leustatin (cladribine), also possesses this activity. FB; Doc. 13562W. $4.95 - Warning Letter Bulletin - ECNext

Custom synthesis of APIs: researchers and process chemists share …  -  Jan 1, 2008
..."Leustatin" (cladribine) by Ortho Biotech and "Fludara" (fludarabine phosphate), developed by Berlex Oncology and now owned by Bayer Healthcare (Leverkusen, ... $9.94 - Pharmaceutical Technology - Alacra Store

Investor Group acquires JB Martin Holding from MRM SA (pending) -...  -  Jun 27, 2007
Smith Barney - Analyst Elaine Leustatin JB Hanors - Analyst Wendy Kaplan Wachovia…John Brooklier, Vice President of Investor Relations for ITW. ... Pay-Per-View - deals - Alacra Store

Leucemia a cellule capellute: trattamento di prima linea con Cladribin...  -  Nov 21, 2006
Il trattamento della leucemia a cellule capellute si basa generalmente sugli analoghi dei nucleotidi purinici, Cladribina ( Leustatin ) e Pentostatina ... XagenaSalute

Investor Group acquires JB Martin SAS through a leveraged buyout -...  -  Jan 15, 2007
Smith Barney - Analyst Elaine Leustatin JB Hanors - Analyst Wendy Kaplan Wachovia…John Brooklier, Vice President of Investor Relations for ITW. ... Pay-Per-View - deals - Alacra Store

Brand Names/Synonyms:
Leustatin is also known by the following brand names and/or synonyms2 Chlorodeoxyadenosine; Chlorodeoxyadenosine; Cladribine; Cladribine [Usan:Ban:Inn]; Leustatin

Drug Category:
Leustatin is categorized under the following by the FDA: Immunosuppressive Agents; Antineoplastic Agents; ATC:L01BB04

Dosage Forms:
SOLUTION

Absorption:
Oral bioavailability is 34-48%

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
5-(6-amino-2-chloro-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy